Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
- Submitting institution
-
Cardiff University / Prifysgol Caerdydd
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 95751332
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(15)00489-1
- Title of journal
- Lancet Oncology
- Article number
- -
- First page
- 243
- Volume
- 17
- Issue
- 2
- ISSN
- 1470-2045
- Open access status
- Out of scope for open access requirements
- Month of publication
- December
- Year of publication
- 2015
- URL
-
http://dx.doi.org/10.1016/S1470-2045%2815%2900489-1
- Supplementary information
-
https://www.thelancet.com/cms/10.1016/S1470-2045%2815%2900489-1/attachment/f65f5310-8410-4a4d-beaf-df47aed92f72/mmc1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
14
- Research group(s)
-
-
- Citation count
- 242
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
-
- Author contribution statement
- a: The author made a substantial contribution to the conception and design of the study, the organisation of the conduct of the study, carrying out the study (including acquisition of study data), analysis and interpretation of study data.
b. The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
